| Literature DB >> 20877208 |
Ales Zima1, Jan Hosek, Jakub Treml, Jan Muselík, Pavel Suchý, Gabriela Prazanová, Ana Lopes, Milan Zemlicka.
Abstract
Antiradical and cytoprotective activities of several flavanones isolated from Paulownia tomentosa (Thunb.) Steud. (Scrophulariaceae) have been evaluated using different in vitro and in vivo methods. The capacity of flavanones to scavenge radicals was measured in vitro by means of DPPH and ABTS assays, the inhibition of hydroxyl radicals produced in Fenton reactions, FRAP, scavenging superoxide radicals using enzymatic and nonenzymatic assays and the inhibition of peroxynitrite-induced nitration of tyrosine. The in vivo testing involved measuring the cytoprotective effect of chosen flavanones against alloxan-induced diabetes in mice. The activity of tested compounds was expressed either as a Trolox® equivalent or was compared with rutin or morine as known antioxidant compounds. The highest activity in most tests was observed for diplacone and 3´-O-methyl-5´-hydroxydiplacone, and the structure vs. the antioxidant activity relationship of geranyl or prenyl-substituted flavonoids with different substitutions at the B and C ring was discussed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20877208 PMCID: PMC6257673 DOI: 10.3390/molecules15096035
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Structures of compounds tested.
| Compound / substituent | R1 | R2 | R3 | R4 | R5 |
|---|---|---|---|---|---|
|
| OH | OH | H | H | |
|
| H | OH | H | H | |
|
| OMe | OH | H | H | |
|
| OMe | OH | H | H | |
|
| OMe | OH | H | OH | |
|
| OMe | OH | OH | H | |
|
| OMe | OH | OMe | H | |
|
| OMe | OH | H | H | |
|
| OH | H | OH | H | |
|
| OMe | OH | H | OH |
Antioxidant activities of compounds 1-9 determined by using ABTS, DPPH, FRAP, the inhibition of tyrosine nitration (activity expressed as TEAC - ability of the sample to scavenge the radical relative to the radical scavenging ability of Trolox®. Value are multiples of activity of Trolox®) and superoxide scavenging activity (expressed as % of inhibition at 50 μM concentration).
| ABTS | DPPH | FRAP | Inhibition of. peroxynitrite induced tyrosine nitration | Superoxide scavenging activity | ||
|---|---|---|---|---|---|---|
| Enzymatic | Non-enzymatic | |||||
|
| 3.2 ± 0.01 | 1.06 ± 0.04 | 0.522 ± 0.01 | 0.84 ± 0.01 | 45.2 | 25.9 |
|
| 1.7 ± 0.01 | 0.02 ± 0.01 | 0.051 ± 0.00 | 0.09 ± 0.01 | -a | -a |
|
| 1.4 ± 0.00 | 0.12 ± 0.02 | 0.118 ± 0.00 | 0.80 ± 0.03 | -a | -a |
|
| 1.61 ± 0.01 | 0.14 ± 0.04 | -a | 0.82 ± 0.01 | -a | -a |
|
| 1.62 ± 0.01 | 0.10 ± 0.00 | 0.127 ± 0.01 | 0.74 ± 0.01 | -a | -a |
|
| 1.66 ± 0.01 | 0.98 ± 0.03 | 0.741 ± 0.01 | 0.84 ± 0.01 | 71.2 | 29.5 |
|
| 1.60 ± 0.01 | 0.29 ± 0.02 | 1.189 ± 0.06 | 0.83 ± 0.02 | -a | -a |
|
| 0.97 ± 0.03 | 0.12 ± 0.00 | -a | 0.82 ± 0.02 | -a | -a |
|
| -a | -a | -a | 0.93 ± 0.02 | -a | -a |
|
| -a | -a | -a | -a | 50.2 | 43.6 |
a Not determined.
Results of Fenton reaction inhibition assay. Rutin at the molar excess of 50:1 or 10:1 to DNA base pare was compared with the tested compounds at the same molar excess. AUC – area under curve; CCC – covalent closed circle (superhelical form of plasmid); L – linear form of plasmid; OC – open circle (circular form of plasmid).
| Compound | AUC | Ratio CCC/ (OC+L) | Compound ratio/Rutin ratio | ||
|---|---|---|---|---|---|
| CCC | OC | L | |||
| 569 | 1618 | 98 | 0.332 | 0.892 | |
| 453 | 3272 | 458 | 0.121 | 0.135 | |
| 708 | 3271 | 231 | 0.202 | 0.543 | |
| 229 | 3170 | 294 | 0.066 | 0.073 | |
| 514 | 2854 | 193 | 0.169 | 0.454 | |
| 564 | 2173 | 73 | 0.251 | 0.279 | |
| 1288 | 3207 | 254 | 0.372 | 1 | |
| 1942 | 1955 | 207 | 0.898 | 1 | |
|
| 2790 | 386 | 193 | 4.819 | - |
| 439 | 634 | - | 0.692 | 0.553 | |
| 152 | 1502 | - | 0.101 | 0.199 | |
| 1289 | 402 | - | 3.206 | 2.565 | |
| 656 | 1406 | - | 0.467 | 0.921 | |
| 194 | 1556 | 96 | 0.117 | 0.094 | |
| 189 | 1915 | 122 | 0.093 | 0.183 | |
| 1055 | 843 | - | 1.251 | 1 | |
| 806 | 1591 | - | 0.507 | 1 | |
|
| 1507 | - | - | - | - |
| 505 | 1379 | - | 0.366 | 0.491 | |
| - | 1373 | - | - | - | |
| 1155 | 1493 | 57 | 0.745 | 1 | |
| 535 | 1788 | 47 | 0.292 | 1 | |
|
| 2166 | 258 | - | 8.395 | - |
Figure 1Levels of glycemia mmol/L as determined in alloxan induced diabetes testing of 1 and 2.
Figure 2Microphotograph of the pancreas of control mice (HE 400×). Pancreatic islets with distinctly-outlined cell borders (physiological findings).
Figure 3Microphotograph of the pancreas of alloxan-treated mice (HE 600×). Rudimental reaction to the destroyed pancreatic islet.
Figure 4Microphotograph of the pancreas – the effect of mimulone (2) on the pancreatic histopathology of diabetic mice (HE 600×). Regressive changes to pancreatic islet cells.
Figure 5Microphotograph of pancreas – the effect of diplacone (1) on the pancreatic histopathology of diabetic mice (HE 600×). Pancreatic islet with an irregular shape; with vacuolised cytoplasm, a pyknotic nucleus and tiny necrosis without a significant inflammatory reaction.
Figure 6Typical electrophoreogram showing the ability of the individual compound to protect DNA in vitro. Lane 1-3: pUC19 + Fenton reaction + 1 (50:1, 10:1, 1:1); Lane 4: pUC19 + 1 50:1; Lane 5-7: pUC19 + Fenton reaction + rutin (50:1, 10:1, 1:1); Lane 8: pUC19 + rutin 50:1; Lane 9: pUC19 + Fenton reaction + DMSO (vehicle); Lane 10: pUC19 L-form; Lane 11: pUC19 native form; Lane 12: ladder.